 | Up a level |
Schwab, Matthias; Chan, Andrew; Eser, Anna-Katharina; Kallmann, Boris; Pöhlau, Dieter; Richter, Joachim; Wagner, Torsten B; Grothe, Christoph (2024). REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program. (In Press). Neurology and therapy Springer 10.1007/s40120-024-00593-x
Le Teuff, Gwénaël; Cozic, Nathalie; Boyer, Jean-Christophe; Boige, Valérie; Diasio, Robert B; Taieb, Julien; Meulendijks, Didier; Palles, Claire; Schwab, Matthias; Deenen, Maarten; Largiadèr, Carlo R; Marinaki, Anthony; Jennings, Barbara A; Wettergren, Yvonne; Di Paolo, Antonello; Gross, Eva; Budai, Barna; Ackland, Stephen P; van Kuilenburg, André B P; McLeod, Howard L; ... (2024). Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis. British journal of cancer, 130(5), pp. 808-818. Springer Nature 10.1038/s41416-023-02517-2
Ghallab, Ahmed; González, Daniela; Strängberg, Ellen; Hofmann, Ute; Myllys, Maiju; Hassan, Reham; Hobloss, Zaynab; Brackhagen, Lisa; Begher-Tibbe, Brigitte; Duda, Julia C; Drenda, Carolin; Kappenberg, Franziska; Reinders, Joerg; Friebel, Adrian; Vucur, Mihael; Turajski, Monika; Seddek, Abdel-Latief; Abbas, Tahany; Abdelmageed, Noha; Morad, Samy A F; ... (2024). Inhibition of the Renal Apical Sodium Dependent Bile Acid Transporter Prevents Cholemic Nephropathy in Mice with Obstructive Cholestasis. Journal of hepatology, 80(2), pp. 268-281. Elsevier 10.1016/j.jhep.2023.10.035
Lumish, Melissa; Thackray, Jennifer; Do, Richard Kinh Gian; Caudle, Kelly E; Amstutz, Ursula; Schwab, Matthias; Diasio, Robert B; Jarnagin, William R; Cercek, Andrea (2023). Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial Floxuridine. JCO precision oncology, 7(e2200442), e2200442. American Society of Clinical Oncology 10.1200/PO.22.00442
Wörmann, Bernhard; Bokemeyer, Carsten; Burmeister, Thomas; Köhne, Claus-Henning; Schwab, Matthias; Arnold, Dirk; Blohmer, Jens-Uwe; Borner, Markus; Brucker, Sara; Cascorbi, Ingolf; Decker, Thomas; de Wit, Maike; Dietz, Andreas; Einsele, Hermann; Eisterer, Wolfgang; Folprecht, Gunnar; Hilbe, Wolfgang; Hoffmann, Jürgen; Knauf, Wolfgang; Kunzmann, Volker; ... (2020). Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper. Oncology research and treatment, 43(11), pp. 628-636. Karger 10.1159/000510258
Bergmeijer, Thomas O; Reny, Jean-Luc; Pakyz, Ruth E; Gong, Li; Lewis, Joshua P; Kim, Eun-Young; Aradi, Daniel; Fernandez-Cadenas, Israel; Horenstein, Richard B; Lee, Ming Ta Michael; Whaley, Ryan M; Montaner, Joan; Gensini, Gian Franco; Cleator, John H; Chang, Kiyuk; Holmvang, Lene; Hochholzer, Willibald; Roden, Dan M; Winter, Stefan; Altman, Russ B; ... (2018). Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC). American Heart Journal, 198, pp. 152-159. Elsevier 10.1016/j.ahj.2017.12.010
Amstutz, Ursula; Henricks, Linda M; Offer, Steven M; Barbarino, Julia; Schellens, Jan H M; Swen, Jesse J; Klein, Teri E; McLeod, Howard L; Caudle, Kelly E; Diasio, Robert B; Schwab, Matthias (2018). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update. Clinical pharmacology and therapeutics, 103(2), pp. 210-216. Wiley 10.1002/cpt.911
Meulendijks, Didier; Henricks, Linda M.; Sonke, Gabe S.; Deenen, Maarten J.; Froehlich, Tanja K.; Amstutz, Ursula; Largiadèr, Carlo R.; Jennings, Barbara A.; Marinaki, Anthony M.; Sanderson, Jeremy D.; Kleibl, Zdenek; Kleiblova, Petra; Schwab, Matthias; Zanger, Ulrich M; Palles, Claire; Tomlinson, Ian; Gross, Eva; van Kuilenburg, André B. P.; Punt, Cornelis J. A.; Koopman, Miriam; ... (2015). Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data. The lancet oncology, 16(16), pp. 1639-1650. Elsevier 10.1016/S1470-2045(15)00286-7
Becquemont, Ana; Amstutz, Ursula; Brauch, Hiltrud; Jacqz-Aigrain, Evelyne; Laurent-Puig, Pierre; A Molina, Miguel; Niemi, Mikko; Schwab, Matthias; A Somogyi, Andrew; Thervet, Eric; Maitland-van der Zee, Anke-Hilse; van Kuilenburg, André; van Schalk, Ron; Verstuyft, Céline; Wadelius, Mia; K Daly, Ann (2011). Practical recommendations for pharmacogenomics - based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics. Pharmacogenomics, 12(1), pp. 113-124. London: Future Medicine 10.2217/pgs.10.147
